MX366113B - Metodos de diganostico y composiciones. - Google Patents

Metodos de diganostico y composiciones.

Info

Publication number
MX366113B
MX366113B MX2017003475A MX2017003475A MX366113B MX 366113 B MX366113 B MX 366113B MX 2017003475 A MX2017003475 A MX 2017003475A MX 2017003475 A MX2017003475 A MX 2017003475A MX 366113 B MX366113 B MX 366113B
Authority
MX
Mexico
Prior art keywords
compositions
diagnostic methods
methods
thermocycling
primers
Prior art date
Application number
MX2017003475A
Other languages
English (en)
Other versions
MX2017003475A (es
Inventor
Tabakman Scott
Lee Josephine
Belhocine Kamila
Richardson Aaron
Wu Indira
Patel Pranav
Original Assignee
Theranos Ip Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2014/056151 external-priority patent/WO2015076919A1/en
Application filed by Theranos Ip Co Llc filed Critical Theranos Ip Co Llc
Publication of MX2017003475A publication Critical patent/MX2017003475A/es
Publication of MX366113B publication Critical patent/MX366113B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00—Apparatus for enzymology or microbiology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6858—Allele-specific amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Sustainable Development (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

La presente invención se refiere a métodos y composiciones para la identificación de información de relación genética. Al menos porciones de los métodos proporcionados en la presente se pueden realizar sin termociclaje. Las composiciones y métodos pueden incluir reactivos tal como polimerasas de ácidos nucleicos y cebadores.
MX2017003475A 2014-09-17 2015-09-17 Metodos de diganostico y composiciones. MX366113B (es)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201462051912P 2014-09-17 2014-09-17
US201462051945P 2014-09-17 2014-09-17
PCT/US2014/056151 WO2015076919A1 (en) 2013-11-22 2014-09-17 Nucleic Acid Amplification
US201462068605P 2014-10-24 2014-10-24
US201462068603P 2014-10-24 2014-10-24
US201562151358P 2015-04-22 2015-04-22
PCT/US2015/050811 WO2016044664A1 (en) 2014-09-17 2015-09-17 Diagnostic methods and compositions

Publications (2)

Publication Number Publication Date
MX2017003475A MX2017003475A (es) 2017-08-02
MX366113B true MX366113B (es) 2019-06-26

Family

ID=55533878

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2017003475A MX366113B (es) 2014-09-17 2015-09-17 Metodos de diganostico y composiciones.
MX2017003473A MX2017003473A (es) 2014-09-17 2015-09-17 Amplificacion hibrida de acido nucleico en multiples pasos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2017003473A MX2017003473A (es) 2014-09-17 2015-09-17 Amplificacion hibrida de acido nucleico en multiples pasos.

Country Status (8)

Country Link
US (3) US9909193B2 (es)
EP (2) EP3194629A4 (es)
JP (6) JP2017531424A (es)
CN (3) CN108026591B (es)
BR (1) BR112017005392A2 (es)
CA (2) CA2961209A1 (es)
MX (2) MX366113B (es)
WO (2) WO2016044664A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112017005392A2 (pt) 2014-09-17 2017-12-12 Theranos Inc amplificação de ácido nucleico multipassos híbrida
US10822648B1 (en) 2016-07-29 2020-11-03 Labrador Diagnostics Llc Hybrid multi-step nucleic acid amplification
BR112019012057A2 (pt) 2016-12-15 2019-11-12 Meharry Medical College agente antiviral, composição farmacêutica para a administração do mesmo e métodos de redução na replicação do vírus zika (zikv) e tratamento de doença mediada pelo vírus zika (zikv)
FI130673B1 (en) * 2020-11-24 2024-01-11 Mobidiag Oy Method and system for performing a cumulative nucleic acid amplification reaction

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
AU730633B2 (en) * 1996-05-29 2001-03-08 Phillip Belgrader Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions
US6743605B1 (en) * 1998-06-24 2004-06-01 Enzo Life Sciences, Inc. Linear amplification of specific nucleic acid sequences
WO2001077317A1 (fr) * 2000-04-07 2001-10-18 Eiken Kagaku Kabushiki Kaisha Procede d'amplification d'acide nucleique par utilisation d'acide nucleique a double brin en tant que modele
US6605451B1 (en) * 2000-06-06 2003-08-12 Xtrana, Inc. Methods and devices for multiplexing amplification reactions
US7041447B2 (en) * 2001-04-09 2006-05-09 St. Jude Children's Hospital, Inc. Haplotyping method for multiple distal nucleotide polymorphisms
EP1319718A1 (en) * 2001-12-14 2003-06-18 Keygene N.V. High throughput analysis and detection of multiple target sequences
JP4517061B2 (ja) * 2003-08-08 2010-08-04 独立行政法人産業技術総合研究所 ダンベル型ｄｎａの効率的な製造方法
JP4379087B2 (ja) * 2003-11-07 2009-12-09 トヨタ自動車株式会社 ゲラニルゲラニル二リン酸合成酵素及びゲラニルゲラニオールの製造方法
WO2005095654A1 (en) * 2004-03-25 2005-10-13 Biohelix Corporation Helicase-dependent amplification of circular nucleic acids
JP4644685B2 (ja) * 2004-07-02 2011-03-02 株式会社ダナフォーム 塩基配列タグの調製方法
JP5438320B2 (ja) * 2005-10-03 2014-03-12 アプライド バイオシステムズ リミテッド ライアビリティー カンパニー 核酸を増幅するための組成物、方法およびキット
US20100240549A1 (en) * 2007-06-22 2010-09-23 The Trustees Of Collumbia University In The City O Specific amplification of tumor specific dna sequences
KR101670621B1 (ko) 2007-10-02 2016-10-28 테라노스, 인코포레이티드 모듈러 현장 진료 장치 및 이의 용도
US20120115140A1 (en) * 2009-04-29 2012-05-10 Js Genetics Inc. Molecular Diagnosis of Fragile X Syndrome Associated with FMR1 Gene
IT1394539B1 (it) * 2009-05-19 2012-07-05 Sentinel Ch S P A Uso di uno stabilizzante delle polimerasi per la liofilizzazione e la preparazione di kit pronti per l'uso
WO2012038049A2 (en) * 2010-09-22 2012-03-29 Roche Diagnostics Gmbh Amplification of distant nucleic acid targets using engineered primers
CN102242211A (zh) * 2011-07-08 2011-11-16 无锡锐奇基因生物科技有限公司 检测突变核酸序列的方法及试剂盒
US8380541B1 (en) 2011-09-25 2013-02-19 Theranos, Inc. Systems and methods for collecting and transmitting assay results
US9619627B2 (en) 2011-09-25 2017-04-11 Theranos, Inc. Systems and methods for collecting and transmitting assay results
US9632102B2 (en) 2011-09-25 2017-04-25 Theranos, Inc. Systems and methods for multi-purpose analysis
US8435738B2 (en) 2011-09-25 2013-05-07 Theranos, Inc. Systems and methods for multi-analysis
JP2014530358A (ja) 2011-09-25 2014-11-17 セラノス， インコーポレイテッド 多重分析のためのシステム及び方法
US9250229B2 (en) 2011-09-25 2016-02-02 Theranos, Inc. Systems and methods for multi-analysis
WO2014025337A1 (en) * 2012-08-06 2014-02-13 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Methods and reagents for amplifying nucleic acids
JP2014140367A (ja) * 2012-12-27 2014-08-07 Tosoh Corp Ｂ型肝炎ウイルスｄｎａ増幅用プライマーおよびそれを用いたｂ型肝炎ウイルスｄｎａ検出法
KR20150132481A (ko) 2013-03-15 2015-11-25 테라노스, 인코포레이티드 핵산 증폭
US9217167B2 (en) * 2013-07-26 2015-12-22 General Electric Company Ligase-assisted nucleic acid circularization and amplification
AU2014353462A1 (en) * 2013-11-22 2016-05-05 Theranos Ip Company, Llc Nucleic acid amplification
BR112017005392A2 (pt) 2014-09-17 2017-12-12 Theranos Inc amplificação de ácido nucleico multipassos híbrida

Also Published As

Publication number Publication date
CN108026591B (zh) 2021-09-07
EP3194590A4 (en) 2018-05-09
CN108026591A (zh) 2018-05-11
CN113736863A (zh) 2021-12-03
US20160201148A1 (en) 2016-07-14
CA2961209A1 (en) 2016-03-24
US20170342476A1 (en) 2017-11-30
JP2022110152A (ja) 2022-07-28
US9909193B2 (en) 2018-03-06
BR112017005392A2 (pt) 2017-12-12
EP3194629A4 (en) 2018-03-07
JP2017532030A (ja) 2017-11-02
WO2016044664A1 (en) 2016-03-24
EP3194590A1 (en) 2017-07-26
MX2017003473A (es) 2017-08-02
JP2017531424A (ja) 2017-10-26
MX2017003475A (es) 2017-08-02
JP2023011943A (ja) 2023-01-24
JP2021006056A (ja) 2021-01-21
US20180223381A1 (en) 2018-08-09
JP2021000138A (ja) 2021-01-07
EP3194629A1 (en) 2017-07-26
CN107002066A (zh) 2017-08-01
WO2016044673A1 (en) 2016-03-24
CA2960859A1 (en) 2016-03-24

Similar Documents

Publication Publication Date Title
MX2015011435A (es) Amplificación de ácidos nucléicos.
EP3169793A4 (en) Isothermal methods for amplifying nucleic acid samples
SG10202108763UA (en) Methods and compositions for nucleic acid analysis
EP3294448A4 (en) Rapid methods for the extraction of nucleic acids from biological samples
WO2015196128A3 (en) Alternative nucleic acid molecules and uses thereof
WO2015196130A3 (en) Alternative nucleic acid molecules and uses thereof
MX2017009506A (es) Polinucleotidos de acido desoxirribonucleico (adn)/acido ribonucleico (arn) hibridos de repeticiones palindromicas cortas agrupadas regularmente separadas (crispr) y sus metodos de uso.
HK1257295A1 (zh) 用於免疫肿瘤学的组合物和方法
MX2017013878A (es) Amplificación de discordancias optimizadas multiplicadas (moma) - reacción en cadena de polimerasa (pcr) en tiempo real, para evaluar el ácido desoxirribonucleico (adn) libre de celula.
EP3234200A4 (en) Compositions and methods for targeted depletion, enrichment, and partitioning of nucleic acids using crispr/cas system proteins
WO2015160895A3 (en) Modified transposases for improved insertion sequence bias and increased dna input tolerance
EP3161162A4 (en) Analysis of nucleic acid sequences
WO2015161054A3 (en) Methods and systems for nucleic acid amplification
EP3541945A4 (en) COMPOSITIONS AND METHODS OF MODIFICATION OF TARGET NUCLEIC ACIDS
MX376755B (es) Detección de ácidos nucleicos diana mediante el uso de hibridación.
IL262019A (en) Nucleic acid stabilizing reagent, kits and methods for its use
HK1256342A1 (zh) 环境或生物样本中的核酸纯化
GB201407334D0 (en) Integrated nucleic acid test system, instrument and method
EA038921B9 (ru) Обнаружение целевой нуклеиновой кислоты и ее вариантов
EP3134551A4 (en) Compositions and methods for enhancing and/or predicting dna amplification
SG11201602686YA (en) Pcr primer set for bacterial dna amplification, kit for detecting and/or identifying bacterial species, and method for detecting and/or identifying bacterial species
EP4461821A3 (en) Polymerase compositions and methods of making and using same
IL260122A (en) Methods and compositions for assembly of nucleic acids
EP3143140A4 (en) Compositions and methods for single-molecule construction of dna
EP3209675A4 (en) Compositions and methods for the detection of nucleic acids

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: THERANOS IP COMPANY, LLC

FG Grant or registration